192 related articles for article (PubMed ID: 25883122)
1. Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.
Graham MM; Wahl RL; Hoffman JM; Yap JT; Sunderland JJ; Boellaard R; Perlman ES; Kinahan PE; Christian PE; Hoekstra OS; Dorfman GS
J Nucl Med; 2015 Jun; 56(6):955-61. PubMed ID: 25883122
[TBL] [Abstract][Full Text] [Related]
2. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
3. Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma.
Daisaki H; Tateishi U; Terauchi T; Tatsumi M; Suzuki K; Shimada N; Nishida H; Numata A; Kato K; Akashi K; Harada M
Ann Nucl Med; 2013 Apr; 27(3):225-32. PubMed ID: 23264065
[TBL] [Abstract][Full Text] [Related]
4. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
Rausch I; Bergmann H; Geist B; Schaffarich M; Hirtl A; Hacker M; Beyer T
Nuklearmedizin; 2014; 53(6):242-8. PubMed ID: 25131649
[TBL] [Abstract][Full Text] [Related]
5. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
6. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 1.0.
Fukukita H; Senda M; Terauchi T; Suzuki K; Daisaki H; Matsumoto K; Ikari Y; Hayashi M
Ann Nucl Med; 2010 May; 24(4):325-34. PubMed ID: 20401547
[TBL] [Abstract][Full Text] [Related]
7. Normal variations and benign findings in pediatric 18F-FDG-PET/CT.
Grant FD
PET Clin; 2014 Apr; 9(2):195-208. PubMed ID: 25030282
[TBL] [Abstract][Full Text] [Related]
8. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
[TBL] [Abstract][Full Text] [Related]
9. [FDG-PET/CT in oncology. German Guideline].
Krause BJ; Beyer T; Bockisch A; Delbeke D; Kotzerke J; Minkov V; Reiser M; Willich N
Nuklearmedizin; 2007; 46(6):291-301. PubMed ID: 18084685
[TBL] [Abstract][Full Text] [Related]
10. Reporting guidance for oncologic 18F-FDG PET/CT imaging.
Niederkohr RD; Greenspan BS; Prior JO; Schöder H; Seltzer MA; Zukotynski KA; Rohren EM
J Nucl Med; 2013 May; 54(5):756-61. PubMed ID: 23575994
[TBL] [Abstract][Full Text] [Related]
11. Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
Iagaru A; Mittra E; Mosci C; Dick DW; Sathekge M; Prakash V; Iyer V; Lapa P; Isidoro J; de Lima JM; Gambhir SS
J Nucl Med; 2013 Feb; 54(2):176-83. PubMed ID: 23243299
[TBL] [Abstract][Full Text] [Related]
12. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
13. Standardization and quantification in PET/CT imaging: tracers beyond FDG.
Antunovic L; Rodari M; Rossi P; Chiti A
PET Clin; 2014 Jul; 9(3):259-66. PubMed ID: 25030389
[TBL] [Abstract][Full Text] [Related]
14. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
[TBL] [Abstract][Full Text] [Related]
15. Aortic 18F-FDG PET/CT uptake pattern at 60 min (early) and 180 min (delayed) acquisition in a control population: a visual and semiquantitative comparative analysis.
Martínez-Rodríguez I; Del Castillo-Matos R; Quirce R; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
Nucl Med Commun; 2013 Sep; 34(9):926-30. PubMed ID: 23797272
[TBL] [Abstract][Full Text] [Related]
16. (18)F-FDG PET/CT imaging in granulomatosis with polyangiitis.
De Geeter F; Gykiere P
Hell J Nucl Med; 2016; 19(1):5-6. PubMed ID: 26929934
[TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
Cerci JJ; Tabacchi E; Bogoni M
PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT Imaging of Carotid Atherosclerosis.
Ali A; Tawakol A
Neuroimaging Clin N Am; 2016 Feb; 26(1):45-54. PubMed ID: 26610659
[TBL] [Abstract][Full Text] [Related]
19. Value of true whole-body FDG-PET/CT scanning protocol in oncology: optimization of its use based on primary diagnosis.
Sebro R; Mari-Aparici C; Hernandez-Pampaloni M
Acta Radiol; 2013 Jun; 54(5):534-9. PubMed ID: 23463863
[TBL] [Abstract][Full Text] [Related]
20. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
